Effectiveness of α-fetoprotein for hepatocellular carcinoma surveillance: The return of the living-dead?

Expert Review of Gastroenterology and Hepatology

Volumn 6, Issue 4, 2012, Pages 441-444

  Giannini, Edoardo G ^a   Erroi, Virginia ^b   Trevisani, Franco ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

fetoprotein; cirrhosis; diagnosis; hepatocellular carcinoma; surveillance; ultrasonography

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; EARLY CANCER; EARLY DIAGNOSIS; ECHOGRAPHY; FALSE POSITIVE RESULT; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

EID: 84865756037     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.12.30     Document Type: Review

References (17)

1. Singal AG, Conjeevaram HS, Volk ML et al. Effectiveness of hepatocellular surveillance in patients with cirrhosis. Cancer Epidemiol. Biomarkers Prev. 21(5), 793-799 (2012).
2. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42(5), 1208-1236 (2005). (Pubitemid 43112690)
3. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 19(3), 329-338 (1999).
4. Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis. Gut 48(2), 251-259 (2001). (Pubitemid 32141852)
5. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma. J. Hepatol. 56(4), 908-943 (2012).
6. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 130(7), 417-422 (2004).
7. Trevisani F, De NS, Rapaccini G et al.; Italian Liver Cancer Group. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am. J. Gastroenterol. 97(3), 734-744 (2002). (Pubitemid 34245906)
8. Stravitz RT, Heuman DM, Chand N et al. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am. J. Med. 121(2), 119-126 (2008). (Pubitemid 351199465)
9. Sangiovanni A, Del Ninno E, Fasani P et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126(4), 1005-1014 (2004). (Pubitemid 38451172)
10. Singal A, Volk ML, Waljee A et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment. Pharmacol. Ther. 30(1), 37-47 (2009).
11. Santi V, Trevisani F, Gramenzi A et al.; Italian Liver Cancer (ITA.LI.CA) Group. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J. Hepatol. 53(2), 291-297 (2010).
12. Andersson KL, Salomon JA, Goldie SJ, Chung RT. Cost-effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin. Gastroenterol. Hepatol. 6(12), 1418-1424 (2008).
13. Singal AG, Yopp A, S Skinner C, Packer M, Lee WM, Tiro JA. Utilization of hepatocellular carcinoma surveillance among american patients: a systematic review. J. Gen. Intern. Med. 27(7), 861-867 (2012).
14. Santi V, Buccione D, Di Micoli A et al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy. J. Hepatol. 56(2), 397-405 (2012).
15. Zhang B, Yang B. Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. J. Med. Screen. 6(2), 108-110 (1999). (Pubitemid 29320849)
16. Sangiovanni A, Manini MA, Iavarone M et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 59(5), 638-644 (2010).
17. Lee JM, Trevisani F, Vilgrain V, Wald C. Imaging diagnosis and staging of hepatocellular carcinoma. Liver Transpl. 17 (Suppl. 2), S34-S43 (2011).